Related Experiment Video

Updated: Aug 9, 2026

Development of Cell-type specific anti-HIV gp120 aptamers for siRNA delivery
13:47

Development of Cell-type specific anti-HIV gp120 aptamers for siRNA delivery

Published on: June 23, 2011

Suppression of human immunodeficiency virus type 1 activity in vitro by oligonucleotides which form intramolecular

R F Rando1, J Ojwang, A Elbaggari

  • 1Triplex Pharmaceutical Corp., Woodlands, Texas 77380.

The Journal of Biological Chemistry
|January 27, 1995
PubMed

Insights

A novel deoxyguanosine and thymidine oligonucleotide (I100-15) inhibits human immunodeficiency virus type-1 (HIV-1) replication by reducing viral transcripts. Modified versions show enhanced potency and duration, suggesting therapeutic potential.

Area of Science:

  • Molecular Biology
  • Virology
  • Medicinal Chemistry

Background:

  • Human immunodeficiency virus type-1 (HIV-1) remains a significant global health challenge.
  • Developing novel antiviral agents with high therapeutic indices is crucial for effective HIV-1 treatment.

Purpose of the Study:

  • To investigate the antiviral activity of a specific oligonucleotide (I100-15) against HIV-1.
  • To elucidate the structure-activity relationship of I100-15 and its derivatives.

Main Methods:

  • Oligonucleotide synthesis and characterization (NMR, polyacrylamide gel electrophoresis).
  • In vitro HIV-1 inhibition assays.
  • Structure/activity relationship studies.

Main Results:

  • I100-15 demonstrated inhibition of HIV-1 by reducing viral transcripts, not by blocking entry.
  • Intramolecular guanosine tetrad formation and specific loop nucleotides were critical for antiviral activity.
  • I100-15 exhibited a high therapeutic index (>100).
  • Cholesterol modification (I100-23) significantly enhanced potency (ED50 < 50 nM) and prolonged viral suppression (>21 days).

Conclusions:

  • Oligonucleotides like I100-15 show promise as novel antiviral agents against HIV-1.
  • Structural features, particularly guanosine tetrads and loop nucleotides, are key to activity.
  • Further investigation of these compounds, especially modified derivatives, is warranted for therapeutic development.

More Related Videos

Nucleocapsid Annealing-Mediated Electrophoresis (NAME) Assay Allows the Rapid Identification of HIV-1 Nucleocapsid Inhibitors08:33

Nucleocapsid Annealing-Mediated Electrophoresis (NAME) Assay Allows the Rapid Identification of HIV-1 Nucleocapsid Inhibitors

Published on: January 19, 2015

Pairwise Growth Competition Assay for Determining the Replication Fitness of Human Immunodeficiency Viruses11:19

Pairwise Growth Competition Assay for Determining the Replication Fitness of Human Immunodeficiency Viruses

Published on: May 4, 2015

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...